Vidofludimus
CAS: 717824-30-1
Ref. 3D-FV102840
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Product Information
- SC12267
- 1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-
- 2-((3-Fluoro-3′-methoxy-[1,1′-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid
- 2-[[(3-Fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-1-cyclopentene-1-carboxylic acid
Vidofludimus is a cytotoxic drug that has been shown to have potent antiproliferative activity. It binds to the mitochondrial membrane potential, inhibiting the production of ATP and inducing apoptosis in cells. Vidofludimus has also been shown to be effective against autoimmune diseases, such as primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). Vidofludimus inhibits the production of cytokines by inhibiting nuclear factor kappa-B (NF-κB), which is an important mediator in the immune response. Vidofludimus has been shown to inhibit the synthesis of nucleotides, which may contribute to its efficacy in treating kidney fibrosis. Vidofludimus is a chemical inhibitor that blocks protein synthesis through inhibition of polysomes in cells.
Chemical properties
Technical inquiry about: 3D-FV102840 Vidofludimus
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.